ATIVS statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Vaccine candidate prediction chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

ATIVS specifications

Information


Unique identifier OMICS_23553
Name ATIVS
Alternative name Analysis Tools for Influenza virus surveillance
Interface Web user interface
Restrictions to use None
Input format XLS,FASTA
Output data An antigenic map.
Programming languages Java
Computer skills Basic
Stability Stable
Maintained Yes

Maintainers


  • person_outline Chao Hsiung <>
  • person_outline Min-Shi Lee <>

Publication for Analysis Tools for Influenza virus surveillance

ATIVS in publications

 (2)
PMCID: 5733358
PMID: 29326687
DOI: 10.3389/fimmu.2017.01760

[…] in the prevention of influenza in young children. the oil-in-water emulsions mf59 and adjuvant systems 03 (as03) have been used as adjuvants in both seasonal adjuvanted trivalent influenza vaccines (ativs) and pandemic monovalent influenza vaccines. compared with non-adjuvanted vaccine responses, these vaccines induce a more robust and persistent antibody response for both homologous […]

PMCID: 4976332
PMID: 27498613
DOI: 10.1038/srep31156

[…] on 120 independent testing set to classify the antigenicity similarity (see )., further, our model was compared with several online programs on independent testing dataset, including lee and chen’s, ativs(liao & lee), lees and shepherd’s and antigenco (). in addition to classification accuracy, parameters of mathew correlation coefficient (mcc) and f-score were also introduced to indicate […]


To access a full list of publications, you will need to upgrade to our premium service.

ATIVS institution(s)
Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, Taiwan; Vaccine R&D Center, National Health Research Institutes, Taiwan
ATIVS funding source(s)
Supported by Centers for Disease Control, Taiwan (DOH95-DC-1401); National Research Program for Genomic Medicine, National Science Council, Taiwan (NSC95-3112-B-400- 005).

ATIVS reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ATIVS